Free Trial
NASDAQ:APGN

Apexigen (APGN) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.39
$0.39
50-Day Range
$0.36
$0.44
52-Week Range
$0.33
$8.28
Volume
N/A
Average Volume
967,731 shs
Market Capitalization
$9.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
APGN stock logo

About Apexigen Stock (NASDAQ:APGN)

Apexigen, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. Apexigen, Inc. was founded in 2010 and is headquartered in San Carlos, California.

APGN Stock News Headlines

[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
APG SGA S.A.
[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
See More Headlines
Receive APGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apexigen and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
7/18/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:APGN
Fax
N/A
Employees
11
Year Founded
N/A

Profitability

Net Income
$-32,070,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($0.09) per share

Miscellaneous

Free Float
20,088,000
Market Cap
$9.57 million
Optionable
Not Optionable
Beta
3.60
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Dr. Xiaodong Yang M.D. (Age 62)
    Ph.D., CEO & Director
    Comp: $532.99k
  • Mr. Francis W. Sarena (Age 52)
    Pres & COO
    Comp: $474.19k
  • Dr. Frank J. Hsu M.D. (Age 62)
    Chief Medical Officer
    Comp: $520.92k
  • Mr. William E. Duke Jr. (Age 51)
    Chief Financial Officer
  • Ms. Amy Wong (Age 57)
    Sr. VP of Fin. & Operations
  • Dr. Jason Wright Ph.D.
    Sr. VP of CMC

This page (NASDAQ:APGN) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners